Pennington, NJ, United States of America

John E Tellew


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: John E Tellew: Innovator in Pharmaceutical Chemistry

Introduction

John E Tellew is a notable inventor based in Pennington, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 3 patents to his name, Tellew's work focuses on innovative solutions for treating various health conditions.

Latest Patents

Among his latest patents, Tellew has developed biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists. These novel biphenyl sulfonamide compounds are designed to act as combined angiotensin and endothelin receptor antagonists. The patents claim methods of using these compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutical compositions containing such compounds.

Career Highlights

Tellew is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work has been instrumental in creating effective therapeutic options for patients suffering from various ailments.

Collaborations

Throughout his career, Tellew has collaborated with esteemed colleagues, including Natesan Murugesan and John E Macor. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in pharmaceutical research.

Conclusion

John E Tellew's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His patents and ongoing work at Bristol-Myers Squibb Company highlight the importance of research in developing new treatments for health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…